GeoVax (GOVXW) Cena un ziņas

SākumlapaGOVXW • NASDAQ

GeoVax

0,036 $

20. jūn., 09:30:12 GMT-4 · USD · NASDAQ · Atruna

Vērtspapīrs tiek tirgots šeit: ASVGalvenā biroja atrašanās vieta: ASV

Slēgšanas kurss

0,036 $

Gada diapazons

0,014 $ - 0,65 $

Tirgus kapitalizāc.

14,42 milj. USD

Vid. apjoms

14,24 tūkst.

Tirgus ziņas

Bloomberg.com

pirms 1 stundas

The Dollar Is Hanging On to Its Haven Role by a Thread, Survey Shows

What it will take for stocks to make a new bear market low

Investor's Business Daily

pirms 2 stundām

Stock Market Today: Dow Jones Rises On Iran News; Tesla Rallies Ahead Of Robotaxi Event (Live Coverage)

Reuters

pirms 25 minūtēm

Wall Street edges up with Trump's Middle East decision in focus

WSJ

pirms 32 minūtēm

Stock Market Today: Oil Prices Drop; Dow Rises After Trump Signals He'll Give Iran Negotiations Time

MarketWatch

pirms 46 minūtēm

Stock Market Today: Dow, S&P 500 and Nasdaq rise as Fed's Waller sees rate cut soon

Par

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia

Ģenerāldirektors

David A. Dodd

Dibināšanas datums

1988

Galvenais birojs

Atlanta, Džordžija
Amerikas Savienotās Valstis

Tīmekļa vietne

geovax.com

Darbinieki